About Invictus Oncology Private Limited
Data last updated: 21 February 2026
Invictus Oncology Private Limited is a private limited company based in Delhi, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 11 April 2011, the company has been in operation for over 15 years.
Registered with ROC Delhi under CIN U24232DL2011PTC217394.
Capital: an authorised share capital of ₹2.1 Cr and a paid-up capital of ₹2.06 Cr. It is led by directors including Raghunath Anant Mashelkar and Rajeev Mantri.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No. 465; F.I.E. 1St Floor Pathparganj Industrial Area, Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.86 Cr, a growth of 20% compared to the previous year.
The company is associated with 1 brand - Invictus Oncology.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website invictusoncology.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressPlot No. 465; F.I.E. 1St Floor Pathparganj Industrial Area, Delhi, Delhi, India – 110092
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Invictus Oncology Private Limited
Invictus Oncology Private Limited operates one associated brand: Invictus Oncology. These brands represent Invictus Oncology Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Chemotherapeutics conjugated with antibodies are developed for cancer treatment. | invictusoncology.com |
Competitors & Alternatives of Invictus Oncology Private Limited
Brands and companies operating in the same space as Invictus Oncology Private Limited include Jazz Pharmaceuticals, C4 Therapeutics, Erasca and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Novel biopharmaceutical medicines are developed for unmet medical needs. | Dublin, Ireland, Ireland | 2003 |
|
|
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | Cambridge, United States, United States | 2016 |
|
|
Small molecule therapeutics for cancer treatment are developed. | San Diego, United States, United States | 2018 |
|
|
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed. | Cambridge, United States, United States | 2009 |
|
|
Antibody-siRNA complexes are developed for cancer treatment. | San Diego, United States, United States | 2012 |
|
|
Therapeutics for cancer and rare diseases are developed. | London, United Kingdom, United Kingdom | 2015 |
|
|
MicroRNA-based therapeutics are developed for treating multiple diseases. | Boulder, United States, United States | 2007 |
Business Activity of Invictus Oncology Private Limited
Invictus Oncology Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details for Invictus Oncology Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Invictus Oncology Private Limited
Invictus Oncology Private Limited is audited by B R MAHESWARI & CO LLP for the financial year 2020. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B R MAHESWARI & CO LLP | Locked | Locked | Locked |
Complete auditor history for Invictus Oncology Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Invictus Oncology Private Limited
Invictus Oncology Private Limited is currently managed by 4 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Raghunath Anant Mashelkar
Also directs:
Sakal Media Private Limited, Akamara Biomedicine Private Limited, Vyome Therapeutics Limited and 5 more
|
Director | 04 Feb 2013 | 13 Years 5 Months | Current |
|
Rajeev Mantri
Also directs:
Akamara Biomedicine Private Limited, Vyome Biosciences Private Limited, Navam Technology Ventures Llp and 5 more
|
Nominee Director | 11 Apr 2011 | 15 Years 3 Months | Current |
|
Shiladitya Sengupta
Also directs:
Akamara Biomedicine Private Limited, Vyome Therapeutics Limited, Vyome Biosciences Private Limited and 1 more
|
Director | 11 Apr 2011 | 15 Years 3 Months | Current |
| Jasmin Rambhai Patel | Nominee Director | 04 Feb 2013 | 13 Years 5 Months | Current |
Financials of Invictus Oncology Private Limited FY 2025 filings available
Invictus Oncology Private Limited reported revenue of ₹2.86 Cr (up 20.00% YoY) for FY 2025.
Ten-year financial statements for Invictus Oncology Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Invictus Oncology Private Limited
Shareholding and ownership data for Invictus Oncology Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Invictus Oncology Private Limited
Invictus Oncology Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Invictus Oncology Private Limited
View historical data on people associated with Invictus Oncology Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Invictus Oncology Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Invictus Oncology Private Limited
GST registrations and filing compliance for Invictus Oncology Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Invictus Oncology Private Limited
Credit ratings, litigation, and regulatory alerts for Invictus Oncology Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Invictus Oncology Private Limited
MSME payment history for Invictus Oncology Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Invictus Oncology Private Limited
Corporate group structure for Invictus Oncology Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Invictus Oncology Private Limited
MCA filings and documents for Invictus Oncology Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Invictus Oncology Private Limited
Recent News on Invictus Oncology Private Limited
Frequently Asked Questions about Invictus Oncology Private Limited
Invictus Oncology Private Limited is an active private limited company in the pharma sector based in Delhi, Delhi, India. It was incorporated on 11 April 2011 (15+ years old) and is registered under CIN U24232DL2011PTC217394.
Invictus Oncology Private Limited reported revenue of ₹2.86 Cr for FY 2025 (up 20.00% YoY).
The current directors of Invictus Oncology Private Limited are:
- Raghunath Anant Mashelkar - Director
- Rajeev Mantri - Nominee Director
- Shiladitya Sengupta - Director
- Jasmin Rambhai Patel - Nominee Director
The primary industry of Invictus Oncology Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Invictus Oncology Private Limited can be reached at the registered office: Plot No. 465; F.I.E. 1St Floor Pathparganj Industrial Area, Delhi, Delhi, India – 110092, or through the website invictusoncology.com.
The authorised capital is ₹2.1 Cr, and the paid-up capital is ₹2.06 Cr.